Distortion product otoacoustic emissions: An objective technique for the screening of hearing loss in children treated with platin derivatives

International Journal of Audiology

Volumn 45, Issue 6, 2006, Pages 337-343

  Dhooge, Ingeborg ^a,b   Dhooge, Catharina ^a   Geukens, Sven ^a   De Clerck, Bieke ^a   De Vel, Eddy ^a   Vinck, Bart M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Department of ENT ^*  (Belgium)

Author keywords

Carboplatin; Children; Cisplatin; DPOAE; High frequency audiometry (HFA); Oototoxicity

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BLEOMYCIN; CARBOPLATIN; CEFTAZIDIME; CEPHALOSPORIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GLYCOPEPTIDE; IFOSFAMIDE; METHOTREXATE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; PLATINUM DERIVATIVE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; AUDIOMETER; AUDIOMETRY; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; FEBRILE NEUTROPENIA; FEMALE; FEVER; FOLLOW UP; HEARING LOSS; HIGH FREQUENCY AUDIOMETRY; HUMAN; INFANT; MALE; NEPHROTOXICITY; NON INVASIVE MEASUREMENT; OTOTOXICITY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CARBOPLATIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CISPLATIN; FEMALE; HEARING LOSS, HIGH-FREQUENCY; HUMANS; MALE; NEOPLASMS; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RETROSPECTIVE STUDIES;

EID: 33750039698     PISSN: 14992027     EISSN: 17088186     Source Type: Journal    
DOI: 10.1080/14992020600582117     Document Type: Article

References (15)

1. Attias, J., Bresloff, I., Reshef, I., Horowitz, G. & Furman, V. 1998. Evaluating noise induced hearing loss with distortion product otoacoustic emissions. Br J Audiol, 32, 39-49.
2. Brock, P.R., Bellman, S.C., Yeomans, E.C., Pinkerton, C.R. & Pritchard, J. 1991. Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol, 19, 295-300.
3. Fausti, S.A., Larson, V.D., Noffsinger, D., Wilson, R.H., Philips, D.S., et al. 1994. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear, 15, 232-239.
4. Freilich, R.J., Kraus, D.H., Budnick, A.S., Bayer, L.A. & Finlay, J.L. 1996. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Med Pediatr Oncol, 26, 95-100.
5. Littman, T.A., Magruder, A. & Strother, D.R. 1998. Monitoring and predicting ototoxic damage using distortion-product otoacoustic emissions: pediatric case study. J Am Acad Audiol, 9, 257-262.
6. Parsons, S.K., Neault, M.W., Lehmann, L.E., Brennan, L.L., Eickhoff, C.E., et al. 1998. Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplant, 22, 669-674.
7. Ress, B.D., Sridhar, K.S., Balkany, T.J., Waxman, G.M., Stagner, B.B., et al. 1999. Effects of cis-platinum chemotherapy on otoacoustic emissions: The development of an objective screening protocol. Third place-Resident Clinical Science Award 1998. Otolaryngol Head Neck Surg, 21, 693-701.
8. Sakamoto, M., Kaga, K. & Kamio, T. 2000. Extended high-frequency ototoxicity induced by the first administration of cisplatin. Otolaryngol Head and Neck Surg, 122, 828-833.
9. Schweitzer, V.G. 1993. Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am, 26, 759-789.
10. Simon, T., Hero, B., Dupuis, W., Selle, B. & Berthold, F. 2002. The incidence of hearing impairment after successful treatment of neuroblastoma. Klin Padiatr, 214, 149-152.
11. Stavroulaki, P., Apostolopoulos, N., Segas, J., Tsakanikos, M. & Adamopoulos, G. 2001. Evoked otoacoustic emissions-an approach for monitoring cisplatin induced ototoxicity in children. Int J Pediatr Otorhinolaryngol, 59, 47-57.
12. Stern, J.W. & Bunin, N. 2002. Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors. Med Pediatr Oncol, 39, 163-167.
13. Vinck, B.M., De Vel, E., Xu, Z.M. & Van Cauwenberge, P.B. 1996. Distortion product otoacoustic emissions: a normative study. Audiology, 35, 231-245.
14. Watanabe, K.C., Jinnouchi, K., Hess, A., Michel, O., Baba, S., et al. 2002. Carboplatin induces less apoptosis in the cochlea of guinea pigs than cisplatin. Chemotherapy, 48, 82-87.
15. Zorowka, P.G., Schmitt, H.J. & Gutjahr, P. 1993. Evoked otoacoustic emissions and pure-tone threshold audiometry in patients receiving cisplatinum therapy. Int J Pediatr Otorhinolaryngol, 25, 73-80.